Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Steroidogenesis Inhibitors (STGI) -- Ignore unavailable to you. Want to Upgrade?

To: caly who wrote (137)	11/7/1999 4:45:00 PM
From: Jim Burnham	Read Replies (1) \| Respond to of 294

This news release kicks asp. <g> This pretty much tells me that the Pashua deal is all ready to go, except for Altachem Pharma. On Friday, Altachem Pharma held a private offering for 1 million. Sounds to me like Altachem Pharma doesn't have the money to match the Pashua proposal and they don't want to lose the opportunity. It is a shame that Altachem is forcing STGI to take legal action. And I hope that the legal action doesn't spook investors. If it does, I'll be buying even more. Heck I'm looking to buy more now, anyway. I don't remember what my mJam recommendation was, but the recommendation I have had for some time is still valid. Buy now for the biggest bang with a bit more risk, or buy after the Pashua deal with very little risk. Both ways will have quite the payoff. Even the safe route could easily do 10x in less than 3 years. Remember that AIDS is just the first step. Aging, MS, Alzheimer's, prostate cancer, depression, Retinitis Pigmentosa, etc. And the drug is a derivitive of a drug used in dentist offices for years and years.